Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 219.25 INR
Change Today 0.00 / 0.00%
Volume 0.0
SVLS On Other Exchanges
Symbol
Exchange
Natl India
As of 7:06 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

suven life sciences ltd (SVLS) Snapshot

Open
220.70
Previous Close
217.00
Day High
225.00
Day Low
216.70
52 Week High
04/15/15 - 338.50
52 Week Low
09/1/14 - 156.60
Market Cap
27.9B
Average Volume 10 Days
645.8K
EPS TTM
0.72
Shares Outstanding
127.3M
EX-Date
07/23/15
P/E TM
303.2x
Dividend
0.60
Dividend Yield
0.27%
Current Stock Chart for SUVEN LIFE SCIENCES LTD (SVLS)

Related News

No related news articles were found.

suven life sciences ltd (SVLS) Related Businessweek News

No Related Businessweek News Found

suven life sciences ltd (SVLS) Details

Suven Life Sciences Limited, a biopharmaceutical company, designs, manufactures, and supplies bulk actives, drug intermediates, and fine chemicals for the life science industry worldwide. It provides advanced intermediates, intermediates, active pharmaceutical ingredients, and stock chemicals. The company also offers contract research and manufacturing services, including development and supply of pharmaceutical and agro chemical intermediates for new chemical entities. In addition, it provides discovery and development of new chemical entities for CNS disorders; research collaborative projects with pharmaceutical companies; and drug discovery research services, such as in-vitro screening and molecular biology, drug metabolism and pharmacokinetics, pharmacology, toxicology, and bioanalysis, as well as operates a formulation development center. The company was formerly known as Suven Pharmaceuticals Pvt. Ltd. and changed its name to Suven Life Sciences Limited in 2003. Suven Life Sciences Limited was founded in 1989 and is based in Hyderabad, India. Suven Life Sciences Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.

881 Employees
Last Reported Date: 05/26/15
Founded in 1989

suven life sciences ltd (SVLS) Top Compensated Officers

Executive Chairman, Chief Executive Officer, ...
Total Annual Compensation: 14.5M
Whole-Time Director, Member of Share Transfer...
Total Annual Compensation: 6.9M
Compensation as of Fiscal Year 2015.

suven life sciences ltd (SVLS) Key Developments

Suven Life Sciences Ltd Board Approves to Create an Overseas Subsidiary

Suven Life Sciences Ltd. has informed that the Board of Directors of the Company at its meeting held on August 14, 2015, has authorized to create an overseas subsidiary with an initial investment of USD 25 million for clinical development and commercialization of Suven pipeline and in-licensed molecules.

Suven Life Sciences Limited Approves Dividend on Equity Shares for the Fiscal Year 2015

Suven Life Sciences Limited has approved the dividend of INR 0.60 per equity share of INR 1 each for the fiscal year 2015 at the AGM held on Aug. 14, 2015.

Suven Life Sciences Limited Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2015

Suven Life Sciences Limited reported unaudited standalone earnings results for the first quarter ended June 30, 2015. For the quarter, the company reported total income from operations (net) of INR 1,009.814 million compared to INR 1,415.316 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 221.345 million compared to INR 514.331 million a year ago. Profit from ordinary activates before tax was INR 262.875 million compared to INR 513.483 million a year ago. Net profit was INR 202.307 million or INR 1.59 per basic and diluted share before and after extraordinary items (not annualized) compared to INR 347.382 million or INR 2.97 per basic and diluted share before and after extraordinary items (not annualized) a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SVLS:IN 219.25 INR 0.00

SVLS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SVLS.
View Industry Companies
 

Industry Analysis

SVLS

Industry Average

Valuation SVLS Industry Range
Price/Earnings 27.4x
Price/Sales 5.6x
Price/Book 4.8x
Price/Cash Flow 25.3x
TEV/Sales 4.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUVEN LIFE SCIENCES LTD, please visit www.suven.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.